FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Credits 2019 Cybersecurity Work

FDA lists six of its 2019 activities to promote medical device cybersecurity safety and awareness.

Medical Devices

Shreis Wins Breakthrough for Tissue Control Device

FDA grants Shreis Scalene Sciences a Breakthrough Device designation for Cytotron, a whole-body therapeutic medical device for use in causing degenera...

Human Drugs

FDA Grants Recro Meloxicam Appeal

FDA grants Recro Pharmas appeal of an agency complete response letter for the firms IV meloxicam.

Human Drugs

ICU Medical Recalls 2 Products Over Particulate Matter

ICU Medical recalls one single lot of lactated ringers injection, USP, and one single lot of 0.9% sodium chloride injection, USP, due to the presence ...

Human Drugs

CARsgen Gains Regenerative Medicine Advanced Therapy Status

FDA grants CARsgen Therapeutics a Regenerative Medicine Advanced Therapy designation for its investigational CT053 CAR-T cell therapy for multiple mye...

Federal Register

Draft Guide on IND Safety Report eSubmissions

Federal Register notice: FDA makes available a draft guidance on Providing Regulatory Submissions in Electronic Format: IND Safety Reports.

Human Drugs

Panel Split on Makenas Withdrawal After Failed Study

In a split vote, FDAs Bone, Reproductive and Urologic Drugs Advisory Committee votes 9 to 7 to recommend that the agency remove from the market Amag P...

Human Drugs

Interim Compounding with Bulk Substances Policy

FDA issues a guidance on an interim regulatory policy for outsourcing facilities compounding drugs from bulk drug substances.

Human Drugs

FDA Partial Hold on Novartis/AveXis AVXS-101 Trials

FDA puts a partial hold on intrathecal clinical trials of Novartis/AveXis AVXS-101.

Medical Devices

Innovative Wants Restrictions on IB-Stim Equivalence

Innovative Health Solutions asks FDA to require preclinical studies and at least one clinical trial to demonstrate substantial equivalence with the IB...